Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10959982 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(14 years from now) | |
US10413525 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(14 years from now) | |
US9839626 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(14 years from now) | |
US11202772 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(14 years from now) |
Market Authorisation Date: 19 July, 2019
Treatment: NA
Dosage: CAPSULE, DELAYED REL PELLETS;ORAL
6
United States
1
India
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic